BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12820368)

  • 21. IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.
    Ferrantini M; Giovarelli M; Modesti A; Musiani P; Modica A; Venditti M; Peretti E; Lollini PL; Nanni P; Forni G
    J Immunol; 1994 Nov; 153(10):4604-15. PubMed ID: 7963533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy by gene transfer with plasmids encoding IL-12/IL-18 is superior to IL-23/IL-18 gene transfer in a rat osteosarcoma model.
    Liebau C; Roesel C; Schmidt S; Karreman C; Prisack JB; Bojar H; Merk H; Wolfram N; Baltzer AW
    Anticancer Res; 2004; 24(5A):2861-7. PubMed ID: 15517889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy.
    Morini M; Albini A; Lorusso G; Moelling K; Lu B; Cilli M; Ferrini S; Noonan DM
    Gene Ther; 2004 Feb; 11(3):284-91. PubMed ID: 14737088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodegradable polymer-based interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity.
    Maheshwari A; Han S; Mahato RI; Kim SW
    Gene Ther; 2002 Aug; 9(16):1075-84. PubMed ID: 12140735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of interleukin-12 transfection on proliferation of ovarian cancer SKOV3 cells in vitro and in vivo].
    Wang J; Zhang CQ; Liu J; Sui LH
    Ai Zheng; 2007 Dec; 26(12):1292-8. PubMed ID: 18076789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-lasting gene expression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL-18 cDNA against rat sarcoma at a distant site.
    Ajiki T; Murakami T; Kobayashi Y; Hakamata Y; Wang J; Inoue S; Ohtsuki M; Nakagawa H; Kariya Y; Hoshino Y; Kobayashi E
    Cancer Gene Ther; 2003 Apr; 10(4):318-29. PubMed ID: 12679805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma.
    Leng J; Zhang L; Yao H; Cao X
    Chin Med J (Engl); 2003 Oct; 116(10):1475-9. PubMed ID: 14570604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model.
    Yamashita YI; Shimada M; Hasegawa H; Minagawa R; Rikimaru T; Hamatsu T; Tanaka S; Shirabe K; Miyazaki JI; Sugimachi K
    Cancer Res; 2001 Feb; 61(3):1005-12. PubMed ID: 11221826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor.
    Kanagawa N; Gao JQ; Motomura Y; Yanagawa T; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
    Biochem Biophys Res Commun; 2008 Aug; 372(4):821-5. PubMed ID: 18519033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
    Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M
    Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma.
    Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F
    Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model.
    Imagawa Y; Satake K; Kato Y; Tahara H; Tsukuda M
    Auris Nasus Larynx; 2004 Sep; 31(3):239-45. PubMed ID: 15364358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination.
    Torrero M; Li S
    Methods Mol Biol; 2008; 423():339-49. PubMed ID: 18370212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation.
    Hara H; Kobayashi A; Narumi K; Kondoh A; Yoshida K; Nishimoto T; Ohashi M; Higashihara E; Ohnami S; Yoshida T; Aoki K
    Cancer Immunol Immunother; 2009 Jul; 58(7):1007-21. PubMed ID: 18998126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy.
    Eslahi NK; Muller S; Nguyen L; Wilson E; Thull N; Rolland A; Pericle F
    Cancer Gene Ther; 2001 Jan; 8(1):55-62. PubMed ID: 11219494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells.
    Luo X; Yu Y; Liang A; Xie Y; Liu S; Guo J; Wang W; Qi R; An H; Zhang M; Xu H; Guo Z; Cao X
    Cell Mol Immunol; 2004 Jun; 1(3):199-204. PubMed ID: 16219168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic IL-12 gene therapy for treating malignancy via intramuscular electroporation.
    Zhu S; Li S
    Methods Mol Biol; 2008; 423():327-37. PubMed ID: 18370211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma.
    Hillman GG; Slos P; Wang Y; Wright JL; Layer A; De Meyer M; Yudelev M; Che M; Forman JD
    Cancer Gene Ther; 2004 Jan; 11(1):61-72. PubMed ID: 14681727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.